Sitka Biopharma, a spin-off company of CDRD Ventures Inc., has developed a novel polymer platform technology that improves drug absorption for cancer treatments. Its lead candidate is a formulation that allows taxane drugs to adhere and penetrate into the bladder wall, enhancing treatment benefit for bladder cancer. Preclinical proof-of-concept has been established and the company’s near term goal is to gain regulatory approval to commence clinical trials.
Company Details
- Founded
- -
- Address
- 2405 Wesbrook Mall, 4th Floor, Vancouver,bc V6t1z3,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sitkabiopharma.com
- Keywords
- bladder cancer, cancer, polymer, biopharmaceuticals, pharmaceuticals, biotechnology, hyperbranched polyglycerols (HPG), drug delivery.
- HQ
- Vancouver, BC
Sitka Biopharma Questions
Sitka Biopharma's website is sitkabiopharma.com
Sitka Biopharma's LinkedIn profile is https://www.linkedin.com/company/sitka-biopharma
Sitka Biopharma's industry is
Biotechnology Research
Sitka Biopharma's top competitors are
Nurse Consulting Canada,
Kapoose Creek Bio,
Metabolica Health Inc.,
Northern Vine Canada,
Lux Bio,
Insight Complete Eye Care Dfw,
Evonik,
Zucara Therapeutics Inc.,
Creatus Biosciences Inc.,
Quark Venture.
Sitka Biopharma's categories are Biotechnology Research
Sitka Biopharma's founding year is 2013
